Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics

Award Notice Posted

Solicitation number
75F40124R00002-Optum-(Lewin)
Agency
Awarded
to The Lewin Group, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75F40124D00044 Federal IDV award
Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services has awarded a multiple award Indefinite Delivery/Indefinite Quantity (ID/IQ) contract for the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). The contract has a $75,000,000.00 IDIQ ceiling for each contract, and the award was made to THE LEWIN GROUP, INC. on 2024-09-26.

Notice text

Multiple Award Indefinite Delivery / Indefinite Quantity (ID/IQ) contract for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3).

$75,000,000.00 IDIQ ceiling for each contract.

Awarded contract 75F40124D00044 to THE LEWIN GROUP, INC. for 75000000.00 on 2024-09-26.

Notice history

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors